DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Parving H-H, Brenner BM, McMurray JJ. et al.
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
N Engl J Med 2012;
367: 2204-2213 doi:10.1056/NEJMoa1208799
We do not assume any responsibility for the contents of the web pages of other providers.